Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03293680
Title Pembrolizumab in Elderly Patients With Advanced Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Lung Cancer Group
Indications

lung non-squamous non-small cell carcinoma

lung squamous cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior
Covered Countries ESP

Additional content available in CKB BOOST